GOP Senator Accuses South Carolina Health Officials of Violating State Law on Medical Cannabis

19 hours ago 3

A high-stakes legal showdown is unfolding in Columbia, South Carolina, as veteran lawmaker Sen. Tom Davis (R) openly accuses the state’s public health regulators of violating state statutes by stalling medical marijuana implementation. Following the federal government’s administrative move shifting regulated medical cannabis products to Schedule III, Davis argues that the Palmetto State’s own trigger laws require administrative compliance that state officials have neglected for nearly six months.

The Standoff Over Statutory Trigger Laws

In a formal two-page letter addressed to Dr. Brannon Traxler, acting director of the South Carolina Department of Public Health (DPH), Senator Davis asserted that the agency lacks the legal authority to pick and choose which federal scheduling changes it reflects in state regulations.

The controversy centers on S.C. Code of Laws § 44-53-160(C), which dictates that whenever a substance is added, deleted, or rescheduled pursuant to federal law or regulation, the state health agency “shall” issue an order synchronizing South Carolina’s controlled substance schedules within 30 days, unless explicitly directed otherwise by the General Assembly. Because the federal order was enacted in late April, Davis noted that the state’s 30-day compliance window officially expired on May 28.

“I write to insist that the Department of Public Health comply with two state statutes it is now violating,” Davis stated in the letter, first highlighted by local outlets and reported by Marijuana Moment. Davis emphasized that neither statute gives the agency discretion, writing that “the Department’s role is ministerial” and that “whether South Carolina should depart from the federal scheduling decision is for the General Assembly alone to decide.”

Selective Enforcement and Longstanding Research Statutes

In addition to the automatic rescheduling trigger, Davis cited the South Carolina Controlled Substances Therapeutic Research Act of 1980 (§ 44-53-610 et seq.). That statute mandates the appointment of an advisory board to assist qualifying patients diagnosed with cancer and glaucoma in obtaining medical cannabis through lawful channels consistent with federal law. According to Davis, the department has failed to convene that panel or establish patient certification pathways.

Davis also drew attention to what he characterized as blatant administrative double standards. He noted that DPH readily utilized the state’s scheduling trigger earlier this year to adopt a strict Schedule I designation for hexahydrocannabinol (HHC) following an enforcement classification from the U.S. Drug Enforcement Administration.

“The Department cannot apply the statute when federal action tightens control of a substance and ignore it when federal action eases control,” Davis maintained.

Broader Political and Cultural Implications

This escalating confrontation matters directly to patients, advocates, and wellness reform communities across the South, where medical cannabis access has long faced significant legislative resistance. For years, medical cannabis proposals sponsored by Davis have passed the South Carolina Senate with bipartisan support, only to stall repeatedly in the state House of Representatives. As a consequence, patients suffering from severe health conditions continue to navigate strict prohibitionary frameworks while neighboring regions advance reform.

The policy bottleneck carries acute cultural and socioeconomic weight. Cannabis prohibition in Southern states has historically fueled disparate enforcement and criminalization across Black and urban communities, while simultaneously blocking accessible natural wellness alternatives and entrepreneurial participation. The ongoing administrative resistance in South Carolina underscores how bureaucratic delays continue to slow broader legal parity and compassionate care.

Seeking authoritative intervention, Davis copied Attorney General Alan Wilson on the correspondence and requested a formal legal opinion on DPH’s statutory obligations. Wilson, who won election as the state’s incoming governor, previously indicated openness to medical cannabis legislation and expressed support for aligning policies with federal rescheduling actions.

Davis has given DPH a 30-day window to provide formal answers outlining why the required rescheduling order has not been transmitted, when the therapeutic research board will be appointed, and what timeline the department will establish to bring South Carolina into full statutory compliance.

This article contains affiliate links. We may earn a commission from qualifying purchases.

Originally referenced from marijuanamoment.net.

The post GOP Senator Accuses South Carolina Health Officials of Violating State Law on Medical Cannabis appeared first on The Hype Magazine.

Read Entire Article